MedPath
NMPA Approval

Compound Paracetamol and Amantadine Hydrochloride Capsules

国药准字H20043058

June 28, 2019

Drug Information

复方氨酚烷胺胶囊

万立克

胶囊剂

(每粒含对乙酰氨基酚0.25克,盐酸金刚烷胺0.1克)复方

化学药品

June 28, 2019

Company Information

Applicant Company

Manufacturing Company

广东省普宁市英歌山工业区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨酚烷胺胶囊 - NMPA 批准文号 | MedPath